HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Choroidal neovascular membrane in persistent fetal vasculature syndrome managed with intravitreal pegaptanib sodium in an infant.

AbstractPURPOSE:
The purpose of this study was to report the successful management of a case of choroidal neovascular membrane secondary to persistent fetal vasculature syndrome in an infant using intravitreal pegaptanib sodium (Macugen).
METHODS:
A 14-month-old male infant developed a peripapillary choroidal neovascular membrane 10 months after lens-sparing vitrectomy that he underwent for persistent fetal vasculature syndrome and confirmed on angiography and optical coherence tomography. A single dose of intravitreal pegaptanib sodium (0.3 mg) was administered after informed consent was obtained. Angiography and optical coherence tomography scans were performed at 6 and 14 weeks after the injection to determine the result.
RESULTS:
Six weeks after the single injection, the lesion reduced in size and exhibited less leakage on angiography. At 14 weeks, leakage was absent, and the lesion had involuted.
CONCLUSION:
Choroidal neovascular membrane in a case of persistent fetal vasculature syndrome is rare. This report shows that intravitreal pegaptanib sodium is highly effective in treating this lesion even in an infant.
AuthorsAnand Vinekar, Newman Sund, Polly Quiram, Antonio Capone Jr
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 30 Issue 4 Suppl Pg. S41-4 (Apr 2010) ISSN: 1539-2864 [Electronic] United States
PMID20419850 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Aptamers, Nucleotide
  • Vascular Endothelial Growth Factor A
  • pegaptanib
Topics
  • Aptamers, Nucleotide (therapeutic use)
  • Choroidal Neovascularization (diagnosis, drug therapy, etiology, physiopathology)
  • Fluorescein Angiography
  • Humans
  • Infant
  • Injections
  • Male
  • Persistent Hyperplastic Primary Vitreous (surgery)
  • Postoperative Complications
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Visual Acuity (physiology)
  • Vitrectomy
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: